Treatment of pregnancy toxaemia with alpha-blocking agents.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000328:Adult; D001921:Brain / Q000098:blood supply; D002199:Capillary Permeability; D004461:Eclampsia / Q000188:drug therapy; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D000860:Hypoxia / Q000150:complications; D007511:Ischemia / Q000150:complications; D007668:Kidney / Q000098:blood supply; D010643:Phenoxybenzamine / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D011225:Pre-Eclampsia / Q000188:drug therapy* / Q000209:etiology; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy; D012131:Respiratory Insufficiency / Q000150:complications; D013035:Spasm; D013565:Sympatholytics / Q000627:therapeutic use*; D014652:Vascular Diseases
D000317:Adrenergic alpha-Antagonists; D013565:Sympatholytics; D010643:Phenoxybenzamine; D010646:Phentolamine